KLK3 and Familial prostate cancer: The prostate cancer data is used as a case study and we have demonstrated that combining genotype information with phenotypes has better predictive performance than using only genotypes or only phenotypes in disease diagnosis, while exceeding the performance of prostate specific antigen (PSA) screening test [23].